ReviewCurrent oncology reports2016

Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted Therapy.

Sangeetha M Reddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.